These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38627989)

  • 1. New-onset of rheumatic diseases following COVID-19 vaccination: the report of three cases and a literature review.
    Matsuda M; Funakubo Asanuma Y; Emoto K; Sakai S; Okumura N; Yazawa H; Maruyama T; Tsuzuki Wada T; Yokota K; Araki Y; Akiyama Y; Mimura T
    Immunol Med; 2024 Sep; 47(3):205-216. PubMed ID: 38627989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Bartels LE; Ammitzbøll C; Andersen JB; Vils SR; Mistegaard CE; Johannsen AD; Hermansen MF; Thomsen MK; Erikstrup C; Hauge EM; Troldborg A
    Rheumatol Int; 2021 Nov; 41(11):1925-1931. PubMed ID: 34476603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis.
    Wang P; Ni J; Chu YY; Chen QQ; Wu GC; Fang Y; Chen C; Zhang RD; Jiang LQ; Zhao Y; Fang X; He J; Wang DG; Wang GH; Pan HF
    Biomed Pharmacother; 2022 Jun; 150():112997. PubMed ID: 35486976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune inflammatory rheumatic diseases post-COVID-19 vaccination.
    Safary A; Esalatmanesh K; Eftekharsadat AT; Jafari Nakjavani MR; Khabbazi A
    Int Immunopharmacol; 2022 Sep; 110():109061. PubMed ID: 35978510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series.
    Colmegna I; Valerio V; Amiable N; Useche M; Rampakakis E; Flamand L; Rollet-Labelle E; Bessette L; Fitzcharles MA; Hazel E; McCormack D; Michou L; Panopalis P; Langlois MA; Bernatsky S; Fortin PR
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 38030231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study.
    Palazzo L; Lindblom J; Kihlgren Olsson E; Nikiphorou E; Wincup C; Saha S; Shaharir SS; Katchamart W; Akarawatcharangura Goo P; Traboco L; Chen YM; Lilleker JB; Nune A; Pauling JD; Agarwal V; Dzifa D; Toro Gutiérrez CE; Caballero-Uribe CV; Chinoy H; ; Agarwal V; Gupta L; Parodis I
    Rheumatol Int; 2024 Oct; 44(10):1923-1933. PubMed ID: 39138675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights of antineutrophil cytoplasmic antibody-associated vasculitis from the perspective of COVID-19 vaccination.
    Yang Y; Xiong Y; Xu G
    Clin Exp Immunol; 2023 Oct; 213(3):301-309. PubMed ID: 37074008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
    Heshin-Bekenstein M; Ziv A; Toplak N; Hagin D; Kadishevich D; Butbul YA; Saiag E; Kaufman A; Shefer G; Sharon O; Pel S; Elkayam O; Uziel Y
    Rheumatology (Oxford); 2022 Nov; 61(11):4263-4272. PubMed ID: 35179569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09:01 allele.
    Kawamura T; Nakazawa D; Nishio S; Isozaki T; Komatsumoto M; Atsumi T
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):426-430. PubMed ID: 36610742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otitis Media with ANCA-Associated Vasculitis Following COVID-19 mRNA Vaccination: A Case Report.
    Yoshino Y; Yamanaka Y; Oda A
    Am J Case Rep; 2024 Sep; 25():e945301. PubMed ID: 39344100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
    Naveen R; Nikiphorou E; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Salim B; Ziade N; Velikova T; Gracia-Ramos AE; Kuwana M; Day J; Makol A; Distler O; Chinoy H; Traboco LS; Wibowo SAK; Tehozol EAZ; Serrano JR; García-De La Torre I; ; Aggarwal R; Gupta L; Agarwal V; Parodis I
    Rheumatology (Oxford); 2023 Jul; 62(7):2453-2463. PubMed ID: 36413073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
    Gianfrancesco M; Hyrich KL; Al-Adely S; Carmona L; Danila MI; Gossec L; Izadi Z; Jacobsohn L; Katz P; Lawson-Tovey S; Mateus EF; Rush S; Schmajuk G; Simard J; Strangfeld A; Trupin L; Wysham KD; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Yazdany J; Machado PM; Robinson PC;
    Ann Rheum Dis; 2020 Jul; 79(7):859-866. PubMed ID: 32471903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
    Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
    Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients.
    Zen M; Fuzzi E; Astorri D; Saccon F; Padoan R; Ienna L; Cozzi G; Depascale R; Zanatta E; Gasparotto M; Benvenuti F; Bindoli S; Gatto M; Felicetti M; Ortolan A; Campaniello D; Larosa M; Lorenzin M; Ramonda R; Sfriso P; Schiavon F; Iaccarino L; Doria A
    J Autoimmun; 2020 Aug; 112():102502. PubMed ID: 32527675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
    Metyas S; Chen C; Aung T; Ballester A; Cheav S
    Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do rheumatic diseases, long-term glucocorticoids, and immunosuppressant treatment, and vaccination impact the COVID-19 severity? Insight from a retrospective cohort study.
    Ma Y; Wei C; Yi Z; Song Z; Cheng Y; Zeng L; Zhao R; Mu R
    Int J Rheum Dis; 2024 Jul; 27(7):e15251. PubMed ID: 38982615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Sim J; Lim CC
    Clin Rheumatol; 2021 Jun; 40(6):2517-2518. PubMed ID: 33928459
    [No Abstract]   [Full Text] [Related]  

  • 18. Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech.
    Suzuki M; Sekiguchi Y; Sasaki M; Inaba S; Oyama S; Inoue Y; Warabi M; Ohashi K; Inoshita S
    Intern Med; 2022; 61(19):2925-2929. PubMed ID: 36184535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New-onset Seropositive Rheumatoid Arthritis Following COVID-19 Vaccination in a Patient with Seronegative Status.
    Yonezawa H; Ohmura SI; Ohkubo Y; Miyamoto T
    Intern Med; 2022 Nov; 61(22):3449-3452. PubMed ID: 36070943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
    Liao HT; Tung HY; Chou CT; Tsai HC; Yen YN; Tsai CY
    Scand J Rheumatol; 2022 Nov; 51(6):500-505. PubMed ID: 35638589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.